Mary Berchtold, Notary Public

Office Manager / Executive Assistant at Jaguar Gene Therapy

Mary Berchtold has extensive work experience in various administrative roles. Mary started their career at Peoples Energy in 2000, where they served as an Administrative Assistant in the Human Resources and Claim/Distribution department. Mary was responsible for a wide range of tasks, including resolving benefit concerns, processing claims, and maintaining personnel files.

In 2005, Mary joined Takeda Pharmaceuticals as a Sr. Administrative Assistant in the Marketing department. Mary later transitioned to the role of Administrative Coordinator, where they supervised and trained new administrative staff. During their time at Takeda, they received awards for their teamwork and contributed to the company's successful merger.

Mary continued their career at Takeda as a Sr. Administrative Assistant in the CNS, Global Therapeutic Area. In this role, they provided support to the Head of Marketed Products Group, Vice Presidents, and Global Product Leaders. Mary'sresponsibilities included calendar management, travel coordination, and organizing meetings.

In 2017, Mary joined AveXis, Inc. as an Executive Assistant, initially supporting the SVP and Chief Business Officer in the Commercial Organization. Mary also managed a team of administrative assistants and received awards for their teamwork and tenacity. Later, they were reassigned to the TechOps Organization to broaden their experience and support a different leader.

In 2020, Mary joined Novartis Gene Therapies (previously AveXis) as an Executive Assistant. Mary continued to provide high-level administrative support until 2021.

Most recently, Mary has been working as an Office Manager/Executive Assistant at Jaguar Gene Therapy since 2021.

Mary Berchtold pursued their education from 1997 to 1999 at MT. SAN JACINTO COLLEGE, where they obtained an Associate of Science degree in Computer Information Systems.

Location

Chicago, United States

Links

Previous companies


Org chart


Teams

This person is not in any teams


Offices


Jaguar Gene Therapy

Jaguar Gene Therapy is accelerating breakthroughs in gene therapy for patients suffering from severe genetic diseases. Led by the former AveXis leadership team and backed by Deerfield Management, a healthcare-specific investment firm, Jaguar brings streamlined R&D, manufacturing and clinical operations to accelerate development and potential approval of therapies for severe genetic diseases.


Industries

Employees

51-200

Links